Roivant Sciences ROIV Earnings Analysis

Earnings Analysis for ROIV – Last 3 Years

Revenue Analysis

The Total Revenue and Operating Revenue have shown slight variations across the reporting periods, with a slight decrease noticed from Q1 2023 ($27.376 million) to Q2 2023 ($21.624 million), but an apparent recovery going into Q3 ($37.101 million) and Q4 ($37.14 million). Gross Profit has followed a similar trend but remained relatively stable in Q3 and Q4 of 2023 at around $33 million.

Cost Management

The Cost of Revenue has remained fairly consistent, showing increments from $4.175 million in Q1 2023 to $4.214 million in Q2, and then a slight decrease thereafter in Q3 ($3.266 million) and Q4 ($3.668 million). Operating Expenses climbed steeply from Q1 ($257.367 million) through Q2 ($281.323 million) and Q3 ($296.339 million), then dropped to $320.999 million in Q4. Total Expenses mirror this trend closely.

Profitability Analysis

The company has witnessed volatile profitability metrics, with EBITDA swinging from -$317.181 million in Q2 2023 to a staggering $5.113 billion in Q4. Similarly, Operating Income has moved from significant losses in the first three quarters to a profit of $5.061 billion in Q4 2023. Pretax Income tells a similar story, finalizing at is $5.098 billion in Q4 after steep negative figures in the prior quarters. Net Income metrics follow this trend as well, particularly impacting the figures in Q4 with approximately $5.096 billion, likely influenced by unusual items.

Cash Flow Indicators

Reconciled Depreciation has shown marginal fluctuations across the quarters, suggesting steady investment into assets, whereas Interest Expense has shown less stability, decreasing slightly from $8.575 million in Q1 2023 to $8.912 million in Q2, and further down to $8.547 million and $9.244 million in the subsequent quarters.

Taxation

The company maintained various tax rates throughout the period, recording a significant tax effect from unusual items especially in Q4, 2023 ($26.689 million) as compared to other quarters. Tax Provision has varied significantly with substantial increases observed in the last quarter of 2023, aligning with the dramatic rise in pre-tax Income.

Shareholder Metrics

Both Diluted and Basic EPS (Earnings Per Share) figures have shown tremendous improvement from massive losses in earlier quarters to $6.03 and $6.37 respectively in the final quarter of 2023. This turnaround indicates significant improvement in profitability which is reflected directly to shareholders. Total Average Shares have remained relatively stable throughout the year.

Conclusion

ROIV has experienced a significant turnaround in its financial performance across 2023, particularly in the last quarter where unusual gains boosted net outcomes. Review and strategic analysis of these unusual items and their sustainability are critical going forward to understand the true operational performance and to steer clear of potential volatility in profitability.

Appendices: Detailed Data Tables and Calculations

(Data tables inclusive of Revenue Reports, Cost Assessments, Profitability Metrics, among others mentioned in the analysis are referred here but not displayed for brevity.)